Want to join the conversation?
Domestic oil and natural gas company $SYRG posted 1Q16 net loss of $51.4MM or $0.42 loss per diluted share vs. net loss of $0.99MM or $0.01 loss per diluted share in 1Q15. 1Q16 net loss includes a full cost ceiling impairment charge of $45.6MM or $0.37 loss per diluted share. Revenues fell 0.67% to $18.27MM vs. 1Q15.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.